Skip to main content
. 2018 Dec 31;36(4):304–316. doi: 10.3857/roj.2018.00416

Fig. 2.

Fig. 2.

Overall survival (OS) and progression-free survival (PFS) rates in all patients with clinically N0 paranasal sinus cancer (n = 124).